Charles River Laboratories CRL Finance Lease Liabilities
Finance Lease Liabilities at other companies
Other financials
Where this comes from
Reported directly by Charles River Laboratories in its filing.
Tagged under the XBRL concept us-gaap:FinanceLeaseLiability.
The official record: Charles River Laboratories’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Charles River Laboratories's finance lease liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Charles River Laboratories's finance lease liabilities?
- Charles River Laboratories (CRL) reported finance lease liabilities of $10.63M in Q1 2026.
- How has Charles River Laboratories's finance lease liabilities changed year-over-year?
- Charles River Laboratories's finance lease liabilities decreased by 63.4% year-over-year, from $29.06M to $10.63M.
- What is the long-term trend for Charles River Laboratories's finance lease liabilities?
- Over 5 years (2020 to 2025), Charles River Laboratories's finance lease liabilities has grown at a -1.1% compound annual growth rate (CAGR), from $26.03M to $24.65M.
- What does finance lease liabilities mean?
- The long-term portion of debt obligations related to finance leases.
- How do you interpret finance lease liabilities?
- An increase indicates a shift toward financing assets through long-term leases, impacting the company's overall leverage profile.
- How does finance lease liabilities compare across companies?
- Comparable to long-term debt metrics in assessing total financial leverage.